Premium
Beclomethasone dipropionate aerosol compared with dry powder in the treatment of asthma
Author(s) -
LAL S.,
MALHOTRA S. M.,
GRIBBEN M. D.,
BUTLER A. G.
Publication year - 1980
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.1980.tb02105.x
Subject(s) - dry powder inhaler , aerosol , asthma , medicine , beclometasone dipropionate , dry cough , corticosteroid , anesthesia , chemistry , inhaler , respiratory disease , organic chemistry , lung
Summary In a double‐blind trial, beclomethasone dipropionate inhaled as a dry powder in doses of 200 μg three times a day was compared with the conventional aerosol of 100 μg three times a day, each for a period of 4 weeks. Neither the dry powder nor the aerosol showed any significant advantage over each other in terms of ventilatory function. Plasma cortisol levels were unaltered with the two medications in spite of the doubled dose of the corticosteroid powder. Choice of one or the other method of administration of medication depended on patient preference and the ease with which he could familiarize himself with either technique.